Fexuprazan
- Generic Name
- Fexuprazan
- Indication
用于胃食管反流病（GERD）的治疗。
Treatment Effect According to Timing of Administration of DWP14012 40 mg
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 186
- Registration Number
- NCT04613895
- Locations
- 🇰🇷
Hanyang University Medical Center, Seoul, Korea, Republic of
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
Phase 1
- Conditions
- Healthy Male Volunteers
- Interventions
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 110
- Registration Number
- NCT04490434
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2019-06-27
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 80
- Registration Number
- NCT03574415
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
Phase 2
Completed
- Conditions
- Erosive Gastroesophageal Reflux Disease
- Interventions
- First Posted Date
- 2017-06-12
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 211
- Registration Number
- NCT03184324
- Locations
- 🇰🇷
Hanyang University Medical Center, Sungdong-gu, Seoul, Korea, Republic of
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 120
- Registration Number
- NCT02757144
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath